Evaluation of Navigation-Assisted TKA Using Mechanical vs. Restricted Kinematic Alignment

Not Applicable

Recruiting

• Conditions: Knee Arthroplasty, Total
• Interventions: Device: Optetrak Logic CR Knee System

• Registration Number: NCT05516381
• Lead Sponsor: Exactech

Brief Summary

The purpose of this study is to evaluate both clinical measures and PROMs in patients undergoing total knee arthroplasty (TKA) using restricted inverse kinematic alignment (iKA) compared to mechanical alignment (MA), both using surgical navigation assistance.

Detailed Description

A prospective randomized clinical study will be conducted.

The study will consist of two cohorts and will collect clinical data from a maximum of 148 knee arthroplasty surgeries during which the patient will receive the Optetrak Logic® CR TKA device. Cohorts will consist of 1) subjects undergoing MA TKA and 2) subjects undergoing restricted iKA TKA. All cohorts will utilize navigation-assisted surgery (ExactechGPS®) and will be enrolled and consented concurrently. Subjects will be randomized and have a 50% chance of being assigned to the MA TKA cohort and a 50% chance of being assigned to the restricted iKA TKA cohort. Study and research staff will be blinded to randomization and the cohort allocation until after consenting and eligibility is determined. Subjects will be blinded to the randomization (MA TKA or restricted iKA TKA) until the completion of the study.

Data collection under this protocol shall be conducted in a way that conforms to any applicable local and national rules, regulations, and guidelines relating to the conduct of clinical research and the protection of human subjects. As appropriate, this may include but is not limited to the following: Good Clinical Practice (GCP) requirements, FDA regulations and guidelines, ISO 14155: 2020, ICH guidelines, HIPAA and other regulations pertaining to the protection of patient data and data privacy, guidelines established by local Institutional Review Boards or similar Ethics Committees, the Belmont Report, and the Declaration of Helsinki.

Study Timeline

• Study First Submitted: 2022-08-19
• Study First Submitted QC: 2022-08-23
• Study First Posted: 2022-08-25
• Study Start: 2023-05-15
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-17
• Last Update Posted: 2024-06-18
• Primary Completion: 2026-12
• Study Completion: 2027-06

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 148

Inclusion Criteria

• Subjects must meet all of the following inclusion criteria to be included in the study:

  1. Subject must be at least 18 years of age at the time of the surgery (skeletally mature)
  2. Subject will receive a Optetrak Logic® CR device per the "Indications for Use" described above
  3. Subject must be willing to comply with the pre-operative and post-operative visit requirements
  4. Subject must be willing and able to provide written informed consent for participation in the study

Exclusion Criteria

• Subjects will be excluded from the study if they meet any of the following exclusion criteria:

  1. Subject with a suspected or confirmed systemic infection and/or a secondary remote infection
  2. Subject without sufficient bone stock to allow appropriate insertion and fixation of the prosthesis
  3. Subject without sufficient soft tissue integrity to provide adequate stability
  4. Subject with either mental or neuromuscular disorders that do not allow control of the knee joint
  5. Subjects whose weight, age, or activity level might cause extreme loads and early failure of the system
  6. Subject is participating in another drug or device study other than knee replacement within the last three (3) months
  7. Subject has behavioral and/or mental issues that may interfere with their ability to follow post-operative instructions
  8. Subject is a prisoner
  9. Subject is pregnant
  10. Subject is undergoing radiation therapy where the targeted field involves the knee joint
  11. Subjects with malignancy involving proximal tibia, distal femur, or knee joint
  12. Subjects undergoing active administration of chemotherapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Mechanical Knee Alignment Technique	Optetrak Logic CR Knee System	Mechanical Knee Alignment Technique
Restricted Invers Kinematic Knee Alignment Technique	Optetrak Logic CR Knee System	Restricted Invers Kinematic Knee Alignment Technique

Primary Outcome Measures

Name	Time	Method
Knee Society Score (KSS)	12-month	Validated outcome score
Knee Injury and Osteoarthritis Outcome Score (KOOS)	12-month	Validated outcome score
Forgotten Joint Score (FJS)	12-month	Validated outcome score
Visual Analog Scale (VAS) - Patient Satisfaction	12-month	Visual scale from 1-10 (high score is better)
Visual Analog Scale (VAS) - Pain	12-month	Visual scale from 1-10 (low score is better)

Secondary Outcome Measures

Name	Time	Method
Knee Alignment	Intraoperative	Characterization of knee in terms of ligament balancing will be assessed through constant-pressure full arc of motion measurement.

Trial Locations

Locations (1)

Fundacio Mutua de Terrassa per a la Docenia i Recera Biomedica i Social, F.P.C.; 🇪🇸 Barcelona, Spain